🌅 Pre-Market Pulse
|
S&P Futures
7,512.00
▲ +9.50 (+0.13%)
|
Nasdaq Futures
30,133.25
▲ +30.25 (+0.10%)
|
Dow Futures
52,660.00
▲ +94.00 (+0.18%)
|
|
10Y Treasury
4.37%
▲ +0.00%
|
US Dollar
101.32
▲ +0.00 (+0.00%)
|
Bitcoin
$59,303
▼ -$858 (-1.43%)
|
Data as of 7:07 AM ET
Good morning! Tuesday, June 30, 2026 is here, and futures are pointing modestly higher to close out the first half of the year. The real action this morning is in biotech and industrials, where fresh clinical trial data and a billion-dollar acquisition are already reshaping the conversation before the opening bell. Here's what's on the radar.
👀 What to Watch Today
Today wraps up the first half of 2026, which means portfolio rebalancing flows could add some extra noise to trading volumes as institutions adjust their positions before the books close. Keep an eye on any unusual volume spikes in large-cap names like SPY and QQQ as that end-of-period reshuffling plays out.On the data front, traders will be watching for any mid-session macro releases that could nudge the 10-year Treasury yield off its current 4.37% anchor. The yield has been remarkably flat overnight, which is giving equities a steady foundation to build on this morning.
The EU's new steel import quota policy kicks in starting today, so expect movement in steel-exposed names as the market prices in what a 50% duty above quota actually means for supply chains and margins. This is a developing story with legs beyond just today.
🌏 Overnight Recap
Overseas markets had a relatively measured overnight session. European equities traded with a cautious tone as the EU's steel quota announcement dominated headlines across the continent, with steelmakers in Germany and France seeing modest moves as traders assessed the downstream impact on manufacturers and auto producers.In Asia, markets closed mixed with no single dominant theme driving broad direction. Currency markets were quiet, with the Dollar Index (DXY) sitting essentially unchanged at 101.32, giving emerging market assets a bit of breathing room heading into the U.S. session.
Bitcoin pulled back overnight, slipping 1.43% to $59,303. Crypto has been drifting lower with no fresh catalyst to spark momentum, and risk appetite in digital assets remains cautious while macro uncertainty lingers in the background.
Sponsored Content
Iran War TRUTH: What Was Revealed Behind Closed Doors
There’s a strategy behind the Iran war. I know because I heard it directly in a closed-door meeting with a source whose connections run deep into global power networks. He walked me through the real purpose and the massive deal tied to it.
📊 Pre-Market Movers
Genmab (GMAB) is the standout mover in pre-market trading after the Danish biotech and its partner AbbVie announced that their lymphoma drug combination hit its primary endpoint in a late-stage clinical trial. That kind of Phase 3 success is exactly what the market rewards, and GMAB is seeing a meaningful uptick as investors reprice the drug's commercial potential.The broader biotech space is worth watching sympathetically today. Positive trial data from one major player often lifts sentiment across the sector, so names like ABBV and peer oncology-focused biotechs could see some spillover momentum heading into the open.
On the deal front, Ipsen's agreement to acquire Karatos Therapeutics for up to $1.75 billion puts a spotlight on navtemadlin, a late-stage drug candidate targeting a rare blood cancer. The acquisition underscores how aggressively mid-size pharma companies are competing to bolster their oncology pipelines, and it keeps M&A as a live theme across the healthcare sector today.
🔍 Today's Watchlist
- GMAB: Genmab shares are on the move after its lymphoma drug combo with AbbVie cleared a late-stage trial endpoint
- Steel sector names: The EU's new 50% tariff above quota kicks in today, watch U.S. and European steel ETFs for reaction
- Ipsen and oncology pipeline plays: The $1.75B Kartos Therapeutics deal highlights continued M&A heat in rare blood cancer treatments
- 10-Year Treasury at 4.37%: Yields are flat but any surprise economic data could shift the rate picture fast
- H1 2026 rebalancing flows: End-of-half institutional repositioning could create unusual volume patterns across major indexes today
Sponsored Content
Market Crash Warning for July 29th
This AI Black Paper is making the rounds on the internet.
And it's easy to see why. Because if this former CIA advisor is right...
It means – as soon as July 29th – we could see an 80% drop in the Dow.
And it's going to start with the massive bubble popping in AI.
If you have money in the markets or assets you need to protect...
I suggest you view this message and move your money NOW.
Because once this crisis hits, I doubt you'll get any second chances.
🎯 The Morning Playbook
The setup for Tuesday is straightforward: modest green across the board, no major yield shock, and a handful of genuine stock-specific catalysts to trade around. Biotech is the sector with the most energy this morning thanks to GMAB, and the steel tariff story gives industrial traders something concrete to work with.With today marking the close of the first half of 2026, there is an argument for staying nimble rather than making bold directional bets. Rebalancing flows can create short-term distortions that do not reflect underlying fundamentals, so do not over-read intraday swings in the indexes.
The cleaner opportunities today are likely in individual names with specific catalysts, not broad macro positioning. Keep your focus tight, let the noise wash through, and remember that how you finish a half matters less than where you are positioned heading into the next one.
🔍 Hand-Picked for You
The Tiny Supplier Behind The Biggest Merger in History (Ad)
Analyst Michael Robinson has identified a tiny, under-the-radar supplier - just 1/60th the size of SpaceX - that he believes sits at the center of Elon Musk's broader AI infrastructure buildout. Once SpaceX goes public this June, Robinson argues Wall Street will inevitably spotlight this overlooked...
Discover the under-the-radar supplier before the IPO deadline arrives.
I Became a Millionaire Here While I Was Still in College (Ad)
This little-known building in Pasadena is where I learned about a kind of investment most people never get access to. Twenty years later, that same opportunity is wide open again. And it's all because of what's about to happen to OpenAI and Anthropic.
Get your free ticker here.
President Trump's 3,642 stock trades REVEALED (Ad)
President Trump just filed a form showing he personally bought millions' worth of Nvidia, Apple, Microsoft, and more. The man has access to more economic intelligence than anyone alive, and he's aggressively buying U.S. stocks. Brett Eversole – who helped predict the Dow would hit 50,000 – says this...
See what he's telling readers to buy now.
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts